Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID‐19: A Multicenter Cohort-Reference-Cited by-同舟云学术

Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID‐19: A Multicenter Cohort

Published:2021-03-15 Issue:9 Volume:27 Page:1343-1347
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Bajaj Jasmohan S.¹²^ORCID,Garcia‐Tsao Guadalupe³,Wong Florence⁴^ORCID,Biggins Scott W.⁵,Kamath Patrick S.⁶,McGeorge Sara¹,Chew Michael³,Pearson Meredith⁵,Shaw Jawaid¹²,Kalluri Anita⁷,Fagan Andrew²,Olofson Amy⁶,Moini Maryam⁴,Rosa Rodriguez Randolph³,Reddy K. Rajender⁷

Affiliation:

1. Department of Medicine Virginia Commonwealth University Richmond VA

2. Department of Medicine Central Virginia Veterans Healthcare System Richmond VA

3. Department of Medicine Yale University Medical Center New Haven CT

4. Department of Medicine University of Toronto Toronto ON Canada

5. Department of Medicine University of Washington Seattle WA

6. Department of Medicine Mayo Clinic College of Medicine and Science Rochester MN

7. Department of Medicine University of Pennsylvania Philadelphia PA

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lt.25981

Reference5 articles.

1. COVID‐19 and CDC.https://www.cdc.gov/coronavirus/2019‐ncov/need‐extra‐precautions/people‐with‐medical‐conditions.html. Accessed December 21 2020.

2. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort

3. Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study

4. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis

5. AASLD Guidance on COVID‐19.https://www.aasld.org/sites/default/files/2020‐06/AASLD‐COVID19‐ExpertPanelConsensusStatement‐June252020‐v2‐FINAL.pdf. Accessed December 21 2020.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Novel Coronavirus Infection on the Course and Prognosis of Cirrhosis;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2024-01-04

2. Thirty-Day readmissions among COVID-19 patients hospitalized during the early pandemic in the United States: Insights from the Nationwide Readmissions Database;Heart & Lung;2023-11

3. Hypocalcemia on Admission Is a Predictor of Disease Progression in COVID-19 Patients with Cirrhosis: A Multicenter Study in Hungary;Biomedicines;2023-05-26

4. Letter to the Editor: Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers;Hepatology Communications;2023-05

5. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups;World Journal of Gastroenterology;2023-04-28